Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Peta · SciRah

Researcher profile · Semantic Scholar

V. Peta

Share profile

V. Peta — researcher profile on SciRah

h-index: 9
Works: 31
Citations: 181

Most-cited papers

Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease
M. Munteanu, R. Pais, V. Peta, O. Deckmyn +13 more
2018Alimentary Pharmacology and Therapeutics41 citations Open access
Semantic Scholar
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19
T. Poynard, O. Deckmyn, M. Rudler, V. Peta +21 more
2020medRxiv19 citations Open access
Semantic Scholar
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
T. Poynard, V. Peta, M. Munteanu, F. Charlotte +9 more
2018European Journal of Gastroenterology and Hepathology19 citations Open access
Semantic Scholar
Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery
V. Peta, C. Tse, H. Perazzo, M. Munteanu +19 more
2017PLoS ONE17 citations Open access
Semantic Scholar
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19
O. Deckmyn, T. Poynard, P. Bedossa, V. Paradis +8 more
2022Biomedicines15 citations Open access
Semantic Scholar
LCR1 and LCR2, two multi‐analyte blood tests to assess liver cancer risk in patients without or with cirrhosis
T. Poynard, V. Peta, O. Deckmyn, M. Munteanu +21 more
2018Alimentary Pharmacology and Therapeutics14 citations Open access
Semantic Scholar
Prospective external validation of a new non‐invasive test for the diagnosis of non‐alcoholic steatohepatitis in patients with type 2 diabetes
T. Poynard, V. Paradis, J. Mullaert, O. Deckmyn +22 more
2021Alimentary Pharmacology and Therapeutics11 citations Open access
Semantic Scholar
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes
T. Poynard, V. Peta, O. Deckmyn, R. Pais +12 more
2019European Journal of Gastroenterology and Hepathology10 citations Open access
Semantic Scholar
Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis
T. Poynard, O. Deckmyn, V. Peta, V. Paradis +6 more
2023Alimentary Pharmacology and Therapeutics9 citations Open access
Semantic Scholar
Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection
P. Maisonnasse, T. Poynard, M. Sakka, S. Akhavan +14 more
2022Gastro Hep Advances6 citations Open access
Semantic Scholar
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
T. Poynard, J. Lacombe, O. Deckmyn, V. Peta +11 more
2021JHEP Reports6 citations Open access
Semantic Scholar
Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia
T. Poynard, O. Deckmyn, V. Peta, Mehdi Sakka +7 more
2023Hepatology Communications5 citations Open access
Semantic Scholar
External validation of an algorithm combining multi‐analyte blood tests (FibroTest‐LCR1‐LCR2) to identify subjects at risk of hepatocellular carcinoma in patients with chronic liver disease
V. Peta, M. Ziol, F. Imbert-Bismut, A. Sutton +13 more
2019GastroHep3 citations Open access
Semantic Scholar
Screening studies of transient elastography and FibroTest in the general population.
T. Poynard, V. Peta, Priscilla Pollo-Flores, M. Munteanu +1 more
2017The Lancet Gastroenterology and Hepatology2 citations
Semantic Scholar
Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
T. Poynard, O. Deckmyn, R. Pais, J. Aron-Wisnewsky +9 more
2025Diagnostics1 citations Open access
Semantic Scholar
External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B
T. Poynard, J. Lacombe, O. Deckmyn, V. Peta +11 more
2022Gastro Hep Advances1 citations Open access
Semantic Scholar
Two new blood tests for identifying patients with chronic liver diseases, at high risk of primary liver cancer
T. Poynard, V. Peta, M. Munteanu, J. Moussalli +23 more
20181 citations
Semantic Scholar
World Journal of Hepatology
V. Peta, Yuliya Sandler, O. Deckmyn, Oksana Duroselle +5 more
1 citations
Semantic Scholar
WED-179 Head-to-head comparison between FibroTest and ELF, for the fibrosis diagnostic in outpatients with type-2 diabetes, using Bayesian latent class models
A. Pilon, M. Vaubourdolle, V. Peta, D. Valla +5 more
2026Journal of Hepatology0 citations
Semantic Scholar
WED-085 Deep learning integration of nuclear magnetic resonance metabolomics and NASH-FibroTest biomarkers improves bloodbased prediction of liver fat measured by magnetic resonance imaging
O. Deckmyn, V. Peta, T. Poynard
2026Journal of Hepatology0 citations
Semantic Scholar
Head-to-head comparison of FibroTest and ELF for diagnosing significant fibrosis (F2-F4) in outpatients with type-2 diabetes using Bayesian latent class models
A. Pilon, M. Vaubourdolle, V. Peta, D. Valla +5 more
2026Scientific Reports0 citations Open access
Semantic Scholar
An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort
T. Poynard, O. Deckmyn, V. Peta, R. Pais +6 more
2025Biomedicines0 citations Open access
Semantic Scholar
WED-487 The blood-based SteatoTest-2 score identifies a previously invisible early steatosis phenotype
T. Poynard, O. Deckmyn, R. Pais, V. Peta +6 more
2025Journal of Hepatology0 citations
Semantic Scholar
WED-486 First construction and validation of new circulating markers (NITs) to assess the risk of early-fibrosis (eF) occurrence in outpatients with type-2 diabetes (T2D) and elevated transaminases
T. Poynard, O. Deckmyn, V. Peta, R. Pais +5 more
2025Journal of Hepatology0 citations
Semantic Scholar
WED-206 Nash-FibroTest for the diagnosis of significant fibrosis, in severe obesity treated with bariatric surgery and external non-linear trajectories of test’ components among obesity classes in a large US population
T. Poynard, O. Deckmyn, R. Pais, J. Aron-Wisnewsky +10 more
2024Journal of Hepatology0 citations
Semantic Scholar
Prospective direct comparisons of four widespread non-invasive fibrosis tests (NITs) in outpatients with type-2 diabetes (T2D) using EPoS histological staging as reference
O. Deckmyn, D. Valla, V. Peta, A. Brzustowski +9 more
2023Journal of Hepatology0 citations
Semantic Scholar
Operating a medical intensive liver unit during a pandemic
P. Maisonnasse, T. Poynard, N. B. Ghedira, Mehdi Sakka +10 more
20210 citations Open access
Semantic Scholar
Conflict of Interest
T. Poynard, V. Peta, O. Deckmyn
2019Journal of Arthroplasty0 citations
Semantic Scholar
THU-484-Mass spectrometric analysis of serum haptoglobin fucolysation in patients stratified according to fibrosis stages, and the presence of hepatocellular carcinoma
V. Peta, D. Lubman, Jian-Hui Zhu, Rezai Keyvan +7 more
2019Journal of Hepatology0 citations
Semantic Scholar
PS-191-External validation of an algorithm combining multi-analyte blood tests (FibroTest-LCR1-LCR2) for identifying subjects at risk of hepatocellular carcinoma among patients with chronic liver disease
V. Peta, M. Ziol, Imbert-Bismut Françoise, A. Sutton +13 more
2019Journal of Hepatology0 citations
Semantic Scholar
Appropriateness of inclusion criteria according to transaminases ALT in studies assessing performances of non-invasive tests in type-2 diabetes patients (T2D)
T. Poynard, F. Charlotte, V. Paradis, Y. Ngo +8 more
20180 citations
Semantic Scholar
Impact of NASH, gender, fasting glucose and body mass index on the liver fibrosis transition rate (FTR) in metabolic liver disease (MLD)
T. Poynard, O. Deckmyn, V. Peta, M. Munteanu +5 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

O. Deckmyn×28
Invite
O. Deckmyn — researcher profile on SciRah
T. Poynard×23
Invite
T. Poynard — researcher profile on SciRah
V. Ratziu×17
Invite
V. Ratziu — researcher profile on SciRah
D. Thabut×16
Invite
D. Thabut — researcher profile on SciRah

×15

Invite

R. Pais — researcher profile on SciRah

Invite

Y. Ngo — researcher profile on SciRah

Invite

C. Housset — researcher profile on SciRah

M. Munteanu×11

Invite

M. Munteanu — researcher profile on SciRah

Invite

T. Poynard — researcher profile on SciRah

F. Charlotte×8

Invite

F. Charlotte — researcher profile on SciRah

Invite

A. Ngo — researcher profile on SciRah

Invite

M. Rudler — researcher profile on SciRah